Table 3.
Reference | Study design | Intervention/duration | Effect size | SASQI score (average)* |
---|---|---|---|---|
De Zeni and Araujo69 | Pre–post | Deep breathing (10 min) | dCCQB = 1.026 | 8/21 |
dVAS = 0.968 | ||||
Eddie et al.39 | Controlled trial | HRVB (3 weeks) | dppc2 = 0.232 | 14.5/21 |
McClernon et al.67 | Crossover trial | Controlled breathing (4 h) | d = 1.498 | 8/21 |
Meule et al.18 | RCT | HRVB (4 weeks) | dppc2 = 0.727 | 14/21 |
Penzlin et al.40 | RCT | HRVB (2 weeks) | dppc2 = 0.074 | 14/21 |
Shahab et al.68 | RCT | Yogic breathing (24 h) | dpost = 0.728 | 15/21 |
d24hr = 0.413 | ||||
Zucker et al.66 | RCT | Portable HRVB (4 weeks) | dppc2 = 0.329 | 11.5/21 |
Average SASQI scores rated independently by two authors.
CCQB, cocaine craving questionnaire-brief; D, Cohen's d; dppc2, effect size based on pooled pretest standard deviation; HRVB, heart rate variability biofeedback; RCT, randomized controlled trial; SASQI, The Scale for Assessing Scientific Quality of Investigations; VAS, visual analog scale.